Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Accumulated Expenses (2016 - 2025)

Innoviva (INVA) has disclosed Accumulated Expenses for 16 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 52.72% year-over-year to $1.6 million, compared with a TTM value of $1.6 million through Dec 2025, down 52.72%, and an annual FY2025 reading of $1.6 million, down 52.72% over the prior year.
  • Accumulated Expenses was $1.6 million for Q4 2025 at Innoviva, down from $6.8 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $38.0 million in Q2 2025 and bottomed at $833000.0 in Q1 2023.
  • Average Accumulated Expenses over 5 years is $6.1 million, with a median of $3.4 million recorded in 2024.
  • The sharpest move saw Accumulated Expenses skyrocketed 508.76% in 2021, then plummeted 52.72% in 2025.
  • Year by year, Accumulated Expenses stood at $4.2 million in 2021, then soared by 93.21% to $8.0 million in 2022, then decreased by 12.49% to $7.0 million in 2023, then tumbled by 51.25% to $3.4 million in 2024, then tumbled by 52.72% to $1.6 million in 2025.
  • Business Quant data shows Accumulated Expenses for INVA at $1.6 million in Q4 2025, $6.8 million in Q3 2025, and $38.0 million in Q2 2025.